International Patent: CAIX-TARGETED SINGLE-DOMAIN ANTIBODIES, BISPECIFIC ANTIBODIES, ANTIBODY-DRUG CONJUGATES, AND USE THEREOF

GENEVA, July 31 -- ZHEJIANG DOER BIOLOGICS CO., LTD. filed a patent application (CN2026/074163) for “CAIX-TARGETED SINGLE-DOMAIN ANTIBODIES, BISPECIFIC ANTIBODIES, ANTIBODY-DRUG CONJUGATES, AND USE THEREOF”. With publication no. WO/2026/158439, here are the other details related to the patent application:

Kind: Initial Publication with ISR [A1]

IPC: C07K 16/30

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Disclaimer: Curated by HT Syndication....